- Home
- MRSN vs SRTS Comparison
MRSN vs SRTS Comparison
Compare MRSN & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- SRTS
- Stock Information
- Founded
- MRSN 2001
- SRTS 2010
- Country
- MRSN United States
- SRTS United States
- Employees
- MRSN N/A
- SRTS N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- SRTS Medical/Dental Instruments
- Sector
- MRSN Health Care
- SRTS Health Care
- Exchange
- MRSN Nasdaq
- SRTS Nasdaq
- Market Cap
- MRSN 47.1M
- SRTS 52.9M
- IPO Year
- MRSN 2017
- SRTS 2016
- Fundamental
- Price
- MRSN $9.76
- SRTS $3.33
- Analyst Decision
- MRSN Strong Buy
- SRTS Strong Buy
- Analyst Count
- MRSN 3
- SRTS 3
- Target Price
- MRSN $33.00
- SRTS $8.00
- AVG Volume (30 Days)
- MRSN 69.2K
- SRTS 82.2K
- Earning Date
- MRSN 11-12-2025
- SRTS 11-06-2025
- Dividend Yield
- MRSN N/A
- SRTS N/A
- EPS Growth
- MRSN N/A
- SRTS N/A
- EPS
- MRSN N/A
- SRTS N/A
- Revenue
- MRSN $34,769,000.00
- SRTS $37,564,000.00
- Revenue This Year
- MRSN N/A
- SRTS N/A
- Revenue Next Year
- MRSN N/A
- SRTS $47.33
- P/E Ratio
- MRSN N/A
- SRTS N/A
- Revenue Growth
- MRSN 16.14
- SRTS 3.29
- 52 Week Low
- MRSN $5.21
- SRTS $3.03
- 52 Week High
- MRSN $70.75
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- MRSN 59.67
- SRTS 52.45
- Support Level
- MRSN $8.76
- SRTS $3.15
- Resistance Level
- MRSN $10.49
- SRTS $3.68
- Average True Range (ATR)
- MRSN 0.84
- SRTS 0.17
- MACD
- MRSN -0.06
- SRTS 0.01
- Stochastic Oscillator
- MRSN 56.87
- SRTS 41.49
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.